Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies.
about
Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of actionDynorphin, stress, and depressionSalvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disordersBeyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Reviewκ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addictionCurrent research on opioid receptor function.Kappa Opioids, Salvinorin A and Major Depressive DisorderNovel molecular targets of dezocine and their clinical implicationsSalvinorin A analogs as probes in opioid pharmacology.Analogues of (3R)-7-hydroxy-N-[(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic). Synthesis and in vitro and in vivo opioid receptor antagonist activity30 years of dynorphins--new insights on their functions in neuropsychiatric diseasesAntidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats.Synergistic antidepressant-like effects between a kappa opioid antagonist (LY2444296) and a delta opioid agonist (ADL5859) in the mouse forced swim test.Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse.Effects of a post-shock injection of the kappa opioid receptor antagonist norbinaltorphimine (norBNI) on fear and anxiety in rats.Investigational drugs for treating major depressive disorder.The kappa opioid receptor: from addiction to depression, and back.Ventral hippocampal kappa opioid receptors mediate the renewal of fear following extinction in the ratIn vivo and in vitro characterization of naltrindole-derived ligands at the κ-opioid receptorAntidepressant-like effects of buprenorphine in rats are strain dependent.The effects of C-terminal modifications on the opioid activity of [N-benzylTyr(1)]dynorphin A-(1-11) analogues.Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphineOpioid receptors: distinct roles in mood disorders.Kappa-opioid system regulates the long-lasting behavioral adaptations induced by early-life exposure to methylphenidate.Bullatine A stimulates spinal microglial dynorphin A expression to produce anti-hypersensitivity in a variety of rat pain modelsNow or Later? An fMRI study of the effects of endogenous opioid blockade on a decision-making network.A large-scale candidate gene analysis of mood disorders: evidence of neurotrophic tyrosine kinase receptor and opioid receptor signaling dysfunction.Dezocine exhibits antihypersensitivity activities in neuropathy through spinal μ-opioid receptor activation and norepinephrine reuptake inhibitionStructure selectivity relationship studies of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives toward the development of the mu opioid receptor antagonists.Structure-Activity Relationships of the Peptide Kappa Opioid Receptor Antagonist Zyklophin.Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework
P2860
Q24642144-14E6C4F5-DA16-4E6C-89BE-ED9A666BCF77Q24650168-9FB4D033-FB2A-4A1E-94E0-55A405FC6CE9Q26781580-FA832305-A259-42E8-8FC3-C6B9323C2D9DQ26782993-2FB5DA88-B6D8-4A09-B338-CD668E84D2C8Q26864309-3D70632E-B977-4315-A172-CF2E77DFC207Q27693220-908A8768-7F28-4049-A589-EB09231D3229Q28075656-31FCC04A-A61F-4F5E-8C8A-4316DB3F1B10Q28658148-E6B59882-7BE5-47E7-BBC8-AD125CE07F83Q30439719-AEFCC908-DE27-4E23-8601-53165460D423Q30474756-703EE7F6-9696-4BF9-BDC8-BC719157C973Q30481450-D663B4F1-6057-4207-98BC-8532F0ABDB43Q33621097-14A6C654-34D5-467F-9047-76381107B879Q33728962-E5687566-2191-4990-8DF1-6CDB64A7E326Q34401390-4679314F-5337-40E1-92F7-66377528FF66Q34482680-75100A70-0458-432E-8105-7CA40227FDF7Q34547274-D7CBEC5F-946F-49DB-BE35-25D076FE47DFQ34650892-587217B7-61E3-4082-BF2C-493E9F8CBDB5Q34722583-3D90F473-6C18-4424-A6B8-682FE3256C7BQ35182618-904C3EB6-0ED1-4B46-AC77-208300D8DBA5Q35243233-E8B631EA-1E86-4157-9619-F056C978AB8CQ36157077-D9EE555C-DDCC-4F30-8762-3E4B202FAE88Q36394777-4C49CE54-3F80-4EA7-8C7F-BD53D94C4DBAQ36675341-9F215298-2888-40FB-BE3B-A884C8F58FB6Q37130532-0D6920B0-B9CB-44C8-8D2D-57196C8F6872Q37220686-85BEF54E-B0E9-4E23-85BC-45EB0B5C3B60Q37311980-0D1E9A4F-28DB-44C5-BD65-4A2C1A0A00B7Q37407150-61A7E789-5ECD-4430-A680-D1EE42AB1997Q37661067-7E5DF3AE-6B68-4701-AE93-39D1624635A9Q38373652-3F93B7F1-4BEE-4E43-ADD7-9EFF64D049A4Q38677168-FA459FD0-8520-4118-8E3F-9C2D6E215F51Q58788199-B5028664-5579-4C6A-BD56-DF2527AF2B92
P2860
Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Central kappa-opioid receptor- ...... BDNF mRNA expression studies.
@ast
Central kappa-opioid receptor- ...... BDNF mRNA expression studies.
@en
type
label
Central kappa-opioid receptor- ...... BDNF mRNA expression studies.
@ast
Central kappa-opioid receptor- ...... BDNF mRNA expression studies.
@en
prefLabel
Central kappa-opioid receptor- ...... BDNF mRNA expression studies.
@ast
Central kappa-opioid receptor- ...... BDNF mRNA expression studies.
@en
P2093
P2860
P1476
Central kappa-opioid receptor- ...... BDNF mRNA expression studies.
@en
P2093
Huina Zhang
James H Woods
Mei-Chuan Ko
Stanley J Watson
Yong-Gong Shi
P2860
P356
10.1016/J.EJPHAR.2007.05.045
P407
P577
2007-06-09T00:00:00Z